E-LIB Suche - Ergebnisse für: Paz-Ares, L.G.

1

OA01.04 First-Line Nivolumab + Ipilimumab + Chemotherapy in..:

Carbone, D.P. ; Paz-Ares, L.G. ; Ciuleanu, T.E....
Journal of Thoracic Oncology. 18 (2023) 3 - p. e2 , 2023

Link: https://doi.org/10.1016/..

2

OA14.03 Six-year Survival and HRQoL Outcomes with 1L Nivolu..:

Ramalingam, S.S. ; Ciuleanu, T.-E. ; Bernabe Caro, R....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S76-S77 , 2023

Link: https://doi.org/10.1016/..

3

PPD04.02 First-Line Nivolumab + Ipilimumab (NIVO+IPI) in Me..:

Borghaei, H. ; Brahmer, J.R. ; Lee, J.-S....
Journal of Thoracic Oncology. 18 (2023) 3 - p. e8-e9 , 2023

Link: https://doi.org/10.1016/..

4

OA01.08 Clinical Response to Tepotinib According to Circula..:

Le, X. ; Paz-Ares, L.G. ; Van Meerbeeck, J....
Journal of Thoracic Oncology. 18 (2023) 3 - p. e3-e4 , 2023

Link: https://doi.org/10.1016/..

5

Long-term survival with first-line nivolumab plus ipilimuma..:

Borghaei, H. ; Ciuleanu, T.-E. ; Lee, J.-S....
Annals of Oncology. 34 (2023) 2 - p. 173-185 , 2023

Link: https://doi.org/10.1016/..

6

Measuring Quality of Life in Low-Risk Prostate Cancer Treat..:

Cascales Garcia, M.A. ; Colmenero, M. ; Rodriguez Antolin, A....
International Journal of Radiation Oncology*Biology*Physics. 96 (2016) 2 - p. E277 , 2016

Link: https://doi.org/10.1016/..

7

Meta-Analysis Examining Impact of Age on Pemetrexed (pem) E..:

Paz-Ares, L.G. ; Zimmermann, A. ; Ciuleanu, T.E....
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S43 , 2014

Link: https://doi.org/10.1016/..

8

Efficacy and safety of maintenance pemetrexed in patients w..:

Scagliotti, G.V. ; Gridelli, C. ; de Marinis, F....
Lung Cancer. 85 (2014) 3 - p. 408-414 , 2014

Link: https://doi.org/10.1016/..

9

9072 POSTER Pemetrexed (Pern) Maintenance Therapy in Elderl..:

Gridelli, C. ; Thomas, M. ; Prabhash, K....
European Journal of Cancer. 47 (2011) - p. S613 , 2011

Link: https://doi.org/10.1016/..

10

1006 The anti-IGF-IR antibody figitumumab (CP-751,871) is a..:

Gualberto, A. ; Hixon, M.L. ; Dolled-Filhart, M.P....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 88-89 , 2009

Link: https://doi.org/10.1016/..

11

First-line Avelumab plus Chemotherapy in Patients with Adva..:

Wheatley, Duncan A. ; Berardi, Rossana ; Climent Duran, Miguel A....
Cancer Research Communications. 4 (2024) 6 - p. 1609-1619 , 2024

Link: https://doi.org/10.1158/..

12

Tepotinib in patients with non-small cell lung cancer with ..:

Le, Xiuning ; Paz-Ares, Luis G. ; Van Meerbeeck, Jan...
Cell Reports Medicine. 4 (2023) 11 - p. 101280 , 2023

Link: https://doi.org/10.1016/..

13

Systemic and Intracranial Outcomes With First-Line Nivoluma..:

Reck, Martin ; Ciuleanu, Tudor-Eliade ; Lee, Jong-Seok...
Journal of Thoracic Oncology. 18 (2023) 8 - p. 1055-1069 , 2023

Link: https://doi.org/10.1016/..

14

Safety of First-Line Nivolumab Plus Ipilimumab in Patients ..:

Paz-Ares, Luis G. ; Ciuleanu, Tudor-Eliade ; Pluzanski, Adam...
Journal of Thoracic Oncology. 18 (2023) 1 - p. 79-92 , 2023

Link: https://doi.org/10.1016/..

15

Response to the Letter to the Editor Titled "First-Line Niv..:

Paz-Ares, Luis G. ; Carbone, David P.
Journal of Thoracic Oncology. 18 (2023) 9 - p. e102-e103 , 2023

Link: https://doi.org/10.1016/..